Search Results - Teun van Gelder

Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity by Qinglian Zhai, Maaike van der Lee, Teun van Gelder, Jesse J. Swen

Connect to this object online.

Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation by Jean-Baptiste Woillard, Michel Mourad, Michael Neely, Arnaud Capron, Ron H. van Schaik, Teun van Gelder, Teun van Gelder, Nuria Lloberas, Dennis A. Hesselink, Pierre Marquet, Vincent Haufroid, Vincent Haufroid, Laure Elens, Laure Elens

Connect to this object online.

The use of a clinical decision support tool to assess the risk of QT drug-drug interactions in community pharmacies by Florine A. Berger, Heleen van der Sijs, Teun van Gelder, Patricia M. L. A. van den Bemt

Connect to this object online.

The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients by Teun van Gelder, Soufian Meziyerh, Soufian Meziyerh, Jesse J. Swen, Aiko P. J. de Vries, Aiko P. J. de Vries, Dirk Jan A. R. Moes

Connect to this object online.

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma by Koen G. A. M. Hussaarts, Leni van Doorn, Sander Bins, Dave Sprengers, Peter de Bruijn, Roelof W. F. van Leeuwen, Stijn L. W. Koolen, Teun van Gelder, Ron H. J. Mathijssen

Connect to this object online.

The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients by Qinglian Zhai, Dirk Jan A. R. Moes, Teun vanGelder, Maaike van derLee, Jan‐Stephan Sanders, Frederike J. Bemelman, Johan W. deFijter, Kathrin Klein, Matthias Schwab, Jesse J. Swen

Connect to this object online.

A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients by Kim L. W. Bunthof, Linda Al‐Hassany, Gizal Nakshbandi, Dennis A. Hesselink, Ron H. N. vanSchaik, Marc A. G. J. ten Dam, Marije C. Baas, Luuk B. Hilbrands, Teun vanGelder

Connect to this object online.

Dynamics of the QTc interval over a 24‐h dose interval after start of intravenous ciprofloxacin or low‐dose erythromycin administration in ICU patients by Florine A. Berger, Willem vanWeteringen, Heleen van derSijs, Nicole G. M. Hunfeld, Jeroen J. H. Bunge, Natasja M. S. deGroot, Patricia M. L. A. van denBemt, Teun vanGelder

Connect to this object online.

Parametric and Nonparametric Population Pharmacokinetic Models to Assess Probability of Target Attainment of Imipenem Concentrations in Critically Ill Patients by Femke de Velde, Brenda C. M. de Winter, Michael N. Neely, Jan Strojil, Walter M. Yamada, Stephan Harbarth, Angela Huttner, Teun van Gelder, Birgit C. P. Koch, Anouk E. Muller, on behalf of the COMBACTE-NET Consortium

Connect to this object online.

Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib by Koen G. A. M. Hussaarts, Leni van Doorn, Karel Eechoute, Jeffrey Damman, Qiang Fu, Nadia van Doorn, Eric D. Eisenmann, Alice A. Gibson, Esther Oomen-de Hoop, Peter de Bruijn, Sharyn D. Baker, Stijn L. W. Koolen, Teun van Gelder, Roelof W. F. van Leeuwen, Ron H. J. Mathijssen, Alex Sparreboom, Sander Bins

Connect to this object online.